Flagship Biosciences, providers of expert tissue data insights, today announced an alliance with Corritori Consulting Inc., a biopharmaceutical and regulatory services advisor, to deliver regulatory strategy and support to clients in the pharmaceutical and companion diagnostics industries.
WESTMINSTER, COLO. (PRWEB) APRIL 30, 2020
Flagship Biosciences, providers of expert tissue data insights, today announced an alliance with Corritori Consulting Inc., a biopharmaceutical and regulatory services advisor. The companies now deliver regulatory strategy and support to clients in the pharmaceutical and companion diagnostics industries. Flagship and Corritori are taking a collaborative approach to empower more confident and informed regulatory decisions through every phase of the drug development life cycle, for faster development and improved patient care and response.
Navigating the complex world of drug and companion diagnostic development can be a challenge. Flagship and Corritori Consulting will help clients at every step of the development process, from early discovery through commercialization, to prepare for review and approval by the FDA as well as ex-US agencies. The alliance builds on pharmaceutical market integration trends as companies attempt to adapt and scale with seamless internal and external collaborations.
“This alliance amplifies Flagship’s ability to offer regulatory and laboratory biomarker development strategies at all stages of the approval process,” said Meredith James, Flagship’s Chief Operating Officer. “Corritori Consulting’s expertise and deep understanding of regulatory standards and pathways provides concise, stepwise regulatory support in a time and cost-efficient manner. Together, Flagship and Corritori integrate seamlessly with a client’s development team through the entire development process to better ensure FDA and therapeutic success.”
“Our scientific and regulatory leadership and client success track record make Corritori Consulting uniquely suited to support the complex development required by Flagship’s clients,” said Suzana Corritori, President of Corritori Consulting. “We offer complementary services and solid experience to help clients be more efficient. With so many agency guidelines and regulations, there are many potential ways to address a challenge and we’re excited to help Flagship’s clients to find the right approach throughout the development process.”
About Flagship Biosciences
Founded in 2009 and headquartered in Westminster, Colorado, Flagship Biosciences, Inc. is a technology-driven tissue analysis services company delivering the most accurate and informative data available. It is revolutionizing tissue analysis to improve drug development and diagnostics using the power of AI with a consultative approach. Flagship’s services and technology dramatically improve on the data and interpretation from traditional pathology methods, eliminating variability and bringing new insights to tissue analysis results. With expert scientific consultation on every project, Flagship’s team interprets results, contextualizes tissue biology, and identifies the best course for success. flagshipbio.com
About Corritori Consulting Inc.
Corritori Consulting Inc. is an Orange County-based drug development consulting service firm founded in 2008 by Suzana Corritori, MD, Ph.D., MSc., whose career spans over 30 years in biopharmaceutical and medical device product development. Corritori Consulting Inc. provides comprehensive, multidimensional drug development and regulatory expertise in both the domestic and international arenas, integrating medical, clinical, nonclinical, and translational science elements for an effective and targeted regulatory product development.
###
For more information please contact Pamela Curran of Stratos Global Marketing, at [email protected] or +1 (303) 818 9316.
Together, Flagship and Corritori integrate seamlessly with a client’s development team through the entire development process to better ensure FDA and therapeutic success.
